Effect of dilazep dihydrochloride on serum cardiac troponin t levels in hemodialysis patients

Kidney and Blood Pressure Research

Volumn 25, Issue 1, 2002, Pages 50-54

  Nakamura, Tsukasa ^a   Ushiyama, Chifuyu ^a   Osada, Shiwori ^a   Ugai, Kazuya ^a   Takahashi, Yutaka ^a   Tanaka, Araki ^a   Shimada, Noriaki ^a   Ebihara, Isao ^a   Koide, Hikaru ^a  

^a KOTO HOSPITAL   (Japan)

Author keywords

Antiplatelet drug; Dilazep; Left ventricular hypertrophy; Myocardial injury; Troponin T

Indexed keywords

DILAZEP; TROPONIN T;

ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; ULTRAFILTRATION;

ADULT; AGED; AGED, 80 AND OVER; DILAZEP; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MYOCARDIUM; RENAL DIALYSIS; TROPONIN T; VASODILATOR AGENTS;

EID: 0036169214     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049435     Document Type: Article

References (32)

1. No association between deletion-type angioten-sin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients
2. Cardiac troponin-I accurately predicts myocardial injury in renal failure
3. Reliability and significance of increased creatinine kinase MB isoenzyme in the serum of uremic patients
4. Increased cardiac troponin T and endothelin-1 concentrations in dialysis patients may indicate heart disease
5. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: A 1-year outcome analysis
6. Effect of dilazep on coronary and systemic circulation
7. Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes
8. Effect of dilazep dihydrochloride on plasma P-selectin concentrations in patients with IgA nephropathy
9. Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy
10. Antigen phenotype and cytotoxic activity of natural killer cells in hemodialysis patients
11. Nutritional assessment and treatment of chronic renal failure
12. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
13. Values of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
14. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease
15. Cardiac troponin T in patients with end-stage renal disease: Absence of expression in truncal skeletal muscle
16. Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim
17. Myocardial cTnT immunoassay as an early discriminator of physiological mechanisms of cardiac hypertrophy
18. Are cardiac troponins reliable serodiagnostic markers of cardiac ischemia in end-stage renal disease?
19. Cardiac troponin T in hemodialyzed patients
20. Evidence for endothelin-1-mediated vaso-constriction in severe heart failure
21. Long-lasting coronary vasoconstrictor effects and myocardial uptake of endothelin-1 in humans
22. Endothelin-1 and its receptor in hypertrophic cardiomyopathy
23. Endothelin and cardiovascular remodeling in end-stage renal disease
24. Cardiac troponin: A new serum marker of myocar-dial injury in sepsis
25. Myocardial cell injury in septic shock
26. Adenosine, the heart and coronary circulation
27. Adenosine and cardioprotection in the diseased heart
28. It is time to ask what adenosine can do for cardioprotection
29. Nucleoside transport inhibition: A therapeutic approach to cardioprotection via adenosine?
30. Dilazep potentiation of adenosine-mediated superior mesenteric arterial vasodilation
31. Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients
32. Dilazep vs. nifedipine in patients with stable effort angina: A double blind randomized study